RFI - Molecular test for detection and/or quantification of hepatitis virus A, B, C, D and E

Informācija

Prior information notice to reduce time limits
01 - Prior information notice
30.03.2023 15:20 (GMT+03:00)
Nē

Pasūtītājs

Norsk Helsenett SF Norsk Helsenett SF
Brian Mariampillai (NHN) Brian Mariampillai
Abels gate 9
Postboks 6123, 7435 TRONDHEIM

7030 TRONDHEIM
Norvēģija
994598759

Lai saņemtu informāciju par iepirkumiem e-pastā, piesakieties, spiežot uz "Saņemt iepirkumu informāciju" lapas lejasdaļā!

The Norwegian Institute of Public Health (NIPH) plan to acquire molecular test for detection and/or quantification of hepatitis virus (A, B, C, D and E) certified in according to the new EU IVDR regulations that will apply from May 2025 (class D).

The virology department at the Norwegian Institute of Public Health is reference laboratory for hepatitis virus in Norway, and hence offer primary, confirmational or supplementary analysis primarily to the microbial laboratories around Norway. The number of samples are generally low compared to the primary microbial laboratories, and varies over time, depending on the demand and ongoing projects. There is therefore a need for a small and flexible system, preferably with automated extraction.

In this regard we would like to have information of test that are or will soon be available on the marked, as well as their specifications. This is in preparation for a tender.

Vēlaties saņemt visaptverošu Jūs interesējošās nozares aktuālo iepirkumu informāciju?

Piesakieties Mercell un saņemiet paziņojumus par jaunākajiem iepirkumiem sev svarīgajās nozarēs 7 dienas bez maksas!

SIA Mercell Latvia

Daļa no Mercell grupas – viens no vadošajiem e-iepirkumu platformu un iepirkumu informācijas piegādātājiem Eiropā.

Par uzņēmumu

Par mums
Kontakti
SIA Mercell Latvia | Dzirnavu iela 37-43, LV-1010 Rīga, Latvija